|
... date and still able to do it." The 36-year-old mother of two sons, Patrick, 20, and Devin, 16, is living with metastatic cancer - cancer originating in her breast and lymph nodes that has spread to her liver, lung and brain. In March 2007, doctors ...
|
|
AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that it has ...
|
|
... OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product ...
|
|
... the meeting. For more information on these items and other research that was presented, go to www.asco.org/ . Breast Cancer The Particulars: Previous studies have shown that adding bevacizumab to taxane chemotherapy agents for patients with ...
|
|
... Track designation from the U.S. Food & Drug Administration (FDA) in combination with docetaxel for progressive metastatic prostate cancer. OGX-011 is currently completing five Phase 2 clinical studies in prostate, lung and breast cancer, and is ...
|
|
Main Category: Lung Cancer Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 23 Aug 2008 - 0:00 PDT printer friendly view / write opinions rate article Human ...
|
|
... is treatment following surgery or local radiation, for patients with hepatocellular carcinoma (HCC), or primary liver cancer. "Nexavar is the only systemic therapy with proven efficacy and tolerability in HCC across multiple patient populations," ...
|
|
... life. Mesothelium refers to the wrapping structure of most of the bodily organs in our body and mesothelioma is the cancer that occurs in mesothelium. Like any other cancerous conditions, abnormal cell growth is observed in the area of mesothelium ...
|
|
... correlation between galectin-9 (Gal-9) expression and metastasis in patients with malignant melanoma and breast cancer. This study verified the ability of Gal-9 to inhibit lung metastasis in experimental mouse models using highly metastatic B16F10 ...
|
|
... MITI) "Up 25.00% in Friday" Micromet, Inc., a biopharmaceutical company, develops antibodies for the treatment of cancer, inflammation, and autoimmune diseases. Its products under preclinical development include MT103 that is developed using BiTE ...
|
|
London, UK, and Cambridge, MA, 15 August 2008 - Antisoma plc today announced survival data from its phase II study of ASA404 in hormone-refractory prostate cancer, in which patients were randomised to receive ...
|
|
Some people whose cancer had spread to different parts of the body had their tumours eradicated by precisely targeted radiation, say researchers who tested the therapy.
|
|
... remained and grew. The team at the University of Chicago Medical Center reported the findings in the journal Clinical Cancer Research. New tumors appeared but the treated tumors were stopped in eight of the patients. Weichselbaum said higher doses ...
|